BAX and neoplasm: The drug combination increases ROS in neutrophils, triggering NET formation (NETosis) and the release of cathepsin G (CTSG), which enters tumor cells via RAGE, cleaves 14-3-3ε, and activates BAX-dependent mitochondrial apoptosis [117].